Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors.
Ann Rheum Dis
; 81(7): e131, 2022 07.
Article
in English
| MEDLINE | ID: covidwho-2309132
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Biological Products
/
Rheumatic Diseases
/
Antirheumatic Agents
/
Janus Kinase Inhibitors
/
COVID-19
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Ann Rheum Dis
Year:
2022
Document Type:
Article
Affiliation country:
Annrheumdis-2020-218152
Similar
MEDLINE
...
LILACS
LIS